NCT05709561

Brief Summary

The research was carried out to determine the effect of acupressure and mindfulness practice to cope with premenstrual syndrome on premenstrual symptoms and quality of life. The sample of the study consisted of a total of 270 students, 90 of which were acupressure, 90 mindfulness and 90 control groups. In the study, data were collected with the Participant Information Form, PMSS and WHOQOL-BREF. The acupressure group was asked to apply acupressure two days a week for 12 weeks, a total of 24 times. In the mindfulness group, 8 weeks of Conscious Awareness Stress Reduction Program was applied, after which the students were asked to practice mindfulness for 3 cycles. Students in both experimental groups were asked to stop the practices after acupressure and mindfulness practices. PMSS and WHOQOL-BREF were applied to both experimental and control groups as an intermediate test 12 weeks after the pre-test and a post-test 24 weeks later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 25, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2023

Completed
Last Updated

July 6, 2023

Status Verified

July 1, 2023

Enrollment Period

Same day

First QC Date

December 25, 2022

Last Update Submit

July 4, 2023

Conditions

Keywords

AcupressureMındfulnessNurseQuality of life

Outcome Measures

Primary Outcomes (1)

  • The Premenstrual Syndrome Scale (PMSS)

    The scale consists of 44 questions. The lowest score that can be obtained from the scale is 44, and the highest score is 220. An increase in the score obtained from the scale indicates that the intensity of PMS symptoms increases. A total score above 110 in the premenstrual syndrome scale indicates the presence of PMS.

    6 month

Secondary Outcomes (1)

  • The World Health Organization Quality of Life Assessment Questionnaire

    6 month

Study Arms (3)

Acupressure Group

ACTIVE COMPARATOR

Acupressure was applied to the acupressure group twice a week in the first week by the researcher. Then, in the second week, it was observed that the students themselves applied this application twice this week under the supervision of the researcher.Then the acupressure group was asked to apply acupressure two days a week for 12 weeks, a total of 24 times.

Procedure: Acupresur

Mindfulness Group

ACTIVE COMPARATOR

The researcher and students practiced mindfulness once a week for 8 weeks. Then the students were asked to do 3 cycles of application alone every day. mid-test was applied.

Procedure: Mindfulness

Plasebo Group

PLACEBO COMPARATOR

Acupressure and mindfulness practices were not applied to the control group and they continued their routine care.

Procedure: Plasebo

Interventions

AcupresurPROCEDURE

acupressure application was applied 2 times a week for a total of 12 weeks and 24 times.

Acupressure Group
MindfulnessPROCEDURE

Mindfulness practice was applied with the students once a week for 8 weeks, accompanied by a researcher. Then, students were asked to apply for 3 cycles.

Mindfulness Group
PlaseboPROCEDURE

No intervention was applied to the control group.

Plasebo Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Regular menstruation (between 21-35 days), being over 18 years old,
  • Being single,
  • Not using analgesics during menstruation,
  • Not having any psychiatric diagnosis or gynecological disease (abnormal uterine bleeding, uterine fibroids, ovarian cysts, etc.),
  • Not using contraceptives,
  • Not having tissue deformities in the extremities and not having any health problems that can prevent physical exercise,
  • A score of \>110 on the PMSS scale.

You may not qualify if:

  • Not participating in at least two mindfulness groups,
  • Not having regular menstruation in the last 3 months,
  • It is the use of analgesics during menstruation during the period of participating in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Simge OZTURK

Malatya, Centre, 44900, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premenstrual Syndrome

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Simge ÖZTÜRK, PHD.Student

    T.R. İNÖNÜ UNIVERSITY SCIENTIFIC RESEARCH AND PUBLICATION ETHICS COMMITTEE 2022/3172

    STUDY CHAIR
  • Sermin TİMUR TAŞHAN, professor

    T.R. İNÖNÜ UNIVERSITY

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Student
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pricipal Investigator

Study Record Dates

First Submitted

December 25, 2022

First Posted

February 2, 2023

Study Start

March 31, 2022

Primary Completion

March 31, 2022

Study Completion

March 15, 2023

Last Updated

July 6, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations